· 丹娜法伯血液肿瘤进修项目主管

· 哈佛医学院副教授

· 淋巴瘤林梦委员会成员

· 国家癌症中心淋巴瘤指南专家组成员

· 淋巴瘤研究基金会科学顾问委员会成员

【专长领域】

· 慢性淋巴细胞白血病

· 霍奇金淋巴瘤

· 非霍奇金淋巴瘤

【研究方向】

· CAR-T

· 慢性淋巴细胞白血病

· 淋巴瘤

· 干细胞/骨髓移植

【教育背景】

1996年毕业于塔夫茨大学医学院，获得博士学位

2001年于布莱根妇女医院完成实习和内科住院医培训

2002年于丹娜法伯/联盟医疗癌症护理完成血液-肿瘤学专科培训

【从医荣誉】(摘选)

顶级医生称号;

病人选择奖;

最富同情心医生奖;

【学术著作】(摘选)

1. Henrich TJ, Hobbs KS, Hanhauser E, Scully E, Hogan LE, Robles YP, Leadabrand KS, Marty FM, Palmer CD, Jost S, K?rner C, Li JZ, Gandhi RT, Hamdan A, Abramson J, LaCasce AS, Kuritzkes DR. Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy. J Infect Dis 2017; 216:254-262.

恶性肿瘤全身化疗后仍存在1型人类免疫缺陷病毒(HIV-1)

2. Ozuah NW, Dahmoush HM, Grant FD, Lehmann LE, LaCasce AS, Billett AL, Margossian SP. Pretransplant functional imaging and outcome in pediatric patients with relapsed/refractory Hodgkin lymphoma undergoing autologous transplantation. Pediatr Blood Cancer 2017.

进行自体移植的复发/难治性霍奇金淋巴瘤儿童患者的移植前功能影像和结果

3. Ozuah NW, LaCasce AS. How to Approach a Patient With Limited Stage Hodgkin Lymphoma Who Remains PET Positive at the End of Chemotherapy: Radiation Therapy? Clin Lymphoma Myeloma Leuk 2017.

如何处理化疗结束时PET仍为阳性的局限期霍奇金淋巴瘤的患者：放射治疗

4. Gibson CJ, Lindsley RC, Tchekmedyian V, Mar BG, Shi J, Jaiswal S, Bosworth A, Francisco L, He J, Bansal A, Morgan EA, Lacasce AS, Freedman AS, Fisher DC, Jacobsen E, Armand P, Alyea EP, Koreth J, Ho V, Soiffer RJ, Antin JH, Ritz J, Nikiforow S, Forman SJ, Michor F, Neuberg D, Bhatia R, Bhatia S, Ebert BL. Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma. J Clin Oncol 2017.

淋巴瘤患者行自体造血干细胞移植治疗后出现克隆性造血及不良结果

5. Herrera AF, Mei M, Low L, Kim HT, Griffin GK, Song JY, Merryman RW, Bedell V, Pak C, Sun H, Paris T, Stiller T, Brown JR, Budde LE, Chan WC, Chen R, Davids MS, Freedman AS, Fisher DC, Jacobsen ED, Jacobson CA, LaCasce AS, Murata-Collins J, Nademanee AP, Palmer JM, Pihan GA, Pillai R, Popplewell L, Siddiqi T, Sohani AR, Zain J, Rosen ST, Kwak LW, Weinstock DM, Forman SJ, Weisenburger DD, Kim Y, Rodig SJ, Krishnan A, Armand P. Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation. J Clin Oncol 2016; 35:24-31.

复发或难治性双表达和双重打击淋巴瘤自体干细胞移植后无进展生存期较差